0000920465-19-000009.txt : 20190109 0000920465-19-000009.hdr.sgml : 20190109 20190109212848 ACCESSION NUMBER: 0000920465-19-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190109 FILED AS OF DATE: 20190109 DATE AS OF CHANGE: 20190109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rolke James CENTRAL INDEX KEY: 0001693858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 19519165 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_154708731010561.xml FORM 4 X0306 4 2019-01-09 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001693858 Rolke James C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2019-01-09 4 P 0 300 6.07 A 75030 D Common Stock 2019-01-09 4 P 0 500 6.09 A 75530 D Common Stock 2019-01-09 4 P 0 800 6.10 A 76330 D /s/ Ryan Murr, as attorney-in-fact for James M. Rolke 2019-01-09